Open Access

[Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway

  • Authors:
    • Aiguo Liu
    • Xuan Gao
    • Qingbin Zhang
    • Lianqun Cui
  • View Affiliations

  • Published online on: September 20, 2017     https://doi.org/10.3892/mmr.2017.7551
  • Pages: 7873-7873
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

November-2017
Volume 16 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu A, Gao X, Zhang Q and Cui L: [Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway. Mol Med Rep 16: 7873-7873, 2017.
APA
Liu, A., Gao, X., Zhang, Q., & Cui, L. (2017). [Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway. Molecular Medicine Reports, 16, 7873-7873. https://doi.org/10.3892/mmr.2017.7551
MLA
Liu, A., Gao, X., Zhang, Q., Cui, L."[Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway". Molecular Medicine Reports 16.5 (2017): 7873-7873.
Chicago
Liu, A., Gao, X., Zhang, Q., Cui, L."[Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway". Molecular Medicine Reports 16, no. 5 (2017): 7873-7873. https://doi.org/10.3892/mmr.2017.7551